Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reiner

Showing results (361-370 of 381) with videos related to

Pageof 39
Sort By:
JAMA Dermatology|August 28, 2014
Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based studyNancy E Thomas, Anne Kricker, Weston T Waxweiler, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.
Neuro-Oncology|July 12, 2025
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practiceEdward K Avila, Anne S Reiner, Terri S Armstrong, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Nature|January 25, 2019
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluidAlexandra M Miller, Ronak H Shah, Elena I Pentsova, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Pageof 39

Showing results (361-370 of 381) with videos related to

Sort By:
Pageof 39
JAMA Dermatology|August 28, 2014
Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based studyNancy E Thomas, Anne Kricker, Weston T Waxweiler, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
The Journal of Investigative Dermatology|August 27, 2017
Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in MelanomaNancy E Thomas, Sharon N Edmiston, Peter A Kanetsky, et al.
Neuro-Oncology|July 12, 2025
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practiceEdward K Avila, Anne S Reiner, Terri S Armstrong, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Nature|January 25, 2019
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluidAlexandra M Miller, Ronak H Shah, Elena I Pentsova, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Pageof 39